{"filing":{"accession_number":"0001213900-26-099871","cik":"0001859807","ticker":"NVACW","company_name":"Profusa, Inc.","form":"8-K","filing_date":"2026-09-15","report_date":"2026-09-09","primary_document":"ea0305121-8k_profusa.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026099871/ea0305121-8k_profusa.htm"},"events":[{"id":33421,"run_id":30729,"accession_number":"0001213900-26-099871","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"Profusa received a Nasdaq Compliance Determination Letter confirming current compliance with the Bid Price Rule and Equity Rule, but is now subject to a one-year Mandatory Panel Monitor period. Critically, if the Company fails to satisfy the Equity Rule during this monitoring period, Nasdaq will issue a delisting determination without allowing a compliance plan or cure period—a material escalation of delisting risk. This disclosure directly addresses the consequences of non-compliance and the heightened threat of delisting, making it a delisting_risk event under Item 8.01.","company_name":"Profusa, Inc.","ticker":"NVACW","filing_date":"2026-09-15","form":"8-K","submitted_at":null,"items":[{"id":36868,"accession_number":"0001213900-26-099871","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"Profusa received a Nasdaq Compliance Determination Letter confirming current compliance with the Bid Price Rule and Equity Rule, but is now subject to a one-year Mandatory Panel Monitor period. Critically, if the Company fails to satisfy the Equity Rule during this monitoring period, Nasdaq will issue a delisting determination without allowing a compliance plan or cure period—a material escalation of delisting risk. This disclosure directly addresses the consequences of non-compliance and the heightened threat of delisting, making it a delisting_risk event under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-15T10:09:44.884439+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36868,"accession_number":"0001213900-26-099871","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"Profusa received a Nasdaq Compliance Determination Letter confirming current compliance with the Bid Price Rule and Equity Rule, but is now subject to a one-year Mandatory Panel Monitor period. Critically, if the Company fails to satisfy the Equity Rule during this monitoring period, Nasdaq will issue a delisting determination without allowing a compliance plan or cure period—a material escalation of delisting risk. This disclosure directly addresses the consequences of non-compliance and the heightened threat of delisting, making it a delisting_risk event under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-15T10:09:44.884439+00:00","company_name":"Profusa, Inc.","ticker":"NVACW","filing_date":"2026-09-15"}]}